Investigational new drugNeuropeptide
Compound 61540
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061540
Risk Class
HIGH
Last Audit
Mar 31, 2108
Research Abstract
Neuropeptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61540 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061540 with updates logged 2108-03-31.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61540Neuropeptide Program 61540
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061540
- [2] Operations Pulse • Neuropeptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61540